Medicis.com Pages on BioPortfolio:

BioPortfolio - Medicis.com
Medicis.com - BioPortfolio. ... 1 Nov 2008 ... Medicis Pharmaceutical - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/_Medicis.com.html...

BioPortfolio - Medicis - Profile
Medicis is the leading independent specialty pharmaceutical company in the United ... Canadian Business Magazine: Nov 18 2008 7:12PM Matching: medicis ...
http://www.bioportfolio.com/biocorporate/26227-Medicis.pdf...

BioPortfolio - Medicis Pharmaceutical - Profile
View the current Medicis Pharmaceutical Page on BioPortfolio.com ... Medicis is a leading specialty pharmaceutical company focusing primarily on developing ...
http://www.bioportfolio.com/biocorporate/6845-Medicis%252BPh...

BioPortfolio - medici Pharma
14 Oct 2008 ... medici Pharma - BioPortfolio. ... Izard Nobel LLP Announces Class Action Lawsuit against Medicis Pharmaceuticals Corporation, Pharma Live: ...
http://www.bioportfolio.com/search/medici_Pharma.html...

BioPortfolio - Rosacea
Medicis is a leading specialty pharmaceutical company focusing primarily on ... Medicis is the leading independent specialty pharmaceutical company in the ...
http://www.bioportfolio.com/indepth/Rosacea.html...

BioPortfolio - Biocorporate Search AZ
Medicis is a leading specialty pharmaceutical company focusing primarily on developing and marketing drugs in the U.S. for the treatment of dermatological,
...
http://www.bioportfolio.com/biocorporate/search/region/AZ.ht...

BioPortfolio - Biocorporate Search
Medici Group. MediciGroup® is one of the most innovative pioneers in patient ... Medicis is a leading specialty pharmaceutical company focusing primarily on ...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...

BioPortfolio - Biocorporate Search
Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and
podiatric ...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...

Results from other life science and pharmaceutical sites:

Ipsen and Medicis announce acceptance of Reloxin BLA in aesthetics ...
19 May 2008 ... n accordance with the agreement between the two parties, Medicis will pay ... approval of the BLA by the FDA, Medicis will pay to Ipsen a ...
http://www.ipsen.com/articles/investorrelations/regulatedinf...

Ipsen and Medicis announce submission of Reloxin BLA in aesthetics ...
17 Mar 2008 ... arrangement between Medicis and Ipsen. Changes from the original BLA ... Ipsen and Medicis teams have worked diligently with FDA to ...
http://www.ipsen.com/articles/investorrelations/regulatedinf...

Medicis to Present At Credit Suisse Healthcare Conference ...
13 Nov 2008 ... 11, 2008 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX - News) today announced that the Company is scheduled to present at the 2008 Credit Suisse ...
http://biz.yahoo.com/pz/081111/154074.html...

BioPortfolio - Medicis Pharmaceutical - Profile
13 Nov 2008 ... View the current Medicis Pharmaceutical Page on BioPortfolio.com ... Medicis is a leading specialty pharmaceutical company focusing ...
http://www.bioportfolio.com/biocorporate/6845-Medicis+Pharma...

Ipsen and Medicis Announce Submission of Reloxin BLA in Aesthetics ...
PARIS and SCOTTSDALE, Ariz., March 17, 2008 (PRIME NEWSWIRE) -- Medicis (NYSE: MRX - News) and Ipsen (Euronext:IPN) today announced that Ipsen has submitted
...
http://biz.yahoo.com/pz/080317/138248.html...

Medicis Announces Third Quarter 2008 Conference Call and Webcast ...
6, 2008 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX - News) today announced it expects to report 2008 third quarter financial results after the market closes on ...
http://biz.yahoo.com/pz/081106/153923.html...

Medicis and Ipsen Announce Submission of Reloxin in Aesthetics to ...
5, 2007 (PRIME NEWSWIRE) -- Medicis (NYSE:MRX - News) and Ipsen (Euronext: FR0010259150; IPN) today announced the submission of a Biologics License ...
http://biz.yahoo.com/pz/071205/132583.html...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.